Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Winans

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Rheumatology Reports|November 5, 2016
Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five YearsZachary Oaks, Thomas Winans, Nick Huang, et al.
ACR Open Rheumatology|April 26, 2024
Redox Pathogenesis in Rheumatic DiseasesOlivia T Laniak, Thomas Winans, Akshay Patel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2016
Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone MiceZachary Oaks, Thomas Winans, Tiffany Caza, et al.
Lancet (London, England)|March 20, 2018
Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trialZhi-Wei Lai, Ryan Kelly, Thomas Winans, et al.
Nature Communications|March 23, 2024
Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activationNick Huang, Thomas Winans, Brandon Wyman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Rheumatology Reports|November 5, 2016
Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five YearsZachary Oaks, Thomas Winans, Nick Huang, et al.
ACR Open Rheumatology|April 26, 2024
Redox Pathogenesis in Rheumatic DiseasesOlivia T Laniak, Thomas Winans, Akshay Patel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2016
Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone MiceZachary Oaks, Thomas Winans, Tiffany Caza, et al.
Lancet (London, England)|March 20, 2018
Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trialZhi-Wei Lai, Ryan Kelly, Thomas Winans, et al.
Nature Communications|March 23, 2024
Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activationNick Huang, Thomas Winans, Brandon Wyman, et al.
Pageof 1